RecruitingNCT06419413

A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

A Transnational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes That May Support Future Development of Personalized Treatment Strategies in Chinese Population


Sponsor

AstraZeneca

Enrollment

355 participants

Start Date

Jan 8, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

A Translational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes associated with Differential Outcomes that may Support Future Development of Personalised Treatment Strategies in Chinese Population


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting detailed information about asthma patients in China — including blood markers, lung function, and other health data — to better understand the different types of asthma and why some people respond differently to treatments. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with asthma by a doctor for at least 3 months - You have acceptable lung function test results - You are willing to follow study procedures **You may NOT be eligible if...** - You have a history of alcohol or drug abuse in the past year - You are currently pregnant - You have a recent respiratory infection (within the past 2 weeks) - You have received a biologic medication within the past 3 months - You have a terminal illness or organ failure - You are on certain asthma medications (like leukotrienes inhibitors) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(21)

Research Site

Chengdu, Sichuan, China

Research Site

Beijing, China

Research Site

Changsha, China

Research Site

Dongguan, China

Research Site

Foshan, China

Research Site

Guangzhou, China

Research Site

Hainan, China

Research Site

Hohhot, China

Research Site

Huizhou, China

Research Site

Kunming, China

Research Site

Nanjing, China

Research Site

Nanning, China

Research Site

Shanghai, China

Research Site

Shenyang, China

Research Site

Taiyuan, China

Research Site

Wenzhou, China

Research Site

Wuhan, China

Research Site

Xi'an, China

Research Site

Xuzhou, China

Research Site

Zhanjiang, China

Research Site

Zhaoqing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06419413


Related Trials